CClinicalTrials.gg
CompletedNCT05278403Updated Jun 22, 2022

Use of Virtual Reality and Video Games in the Physiotherapy Treatment of Stroke Patients

An interventional study of Virtual reality and video games and Neurological physiotherapy in Stroke, Virtual Reality and Physical Therapy, sponsored by Universidad de Murcia. Completed at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-06-22.

Sponsored by Universidad de Murcia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Randomized clinical trial based on the application of virtual reality and video games together with physiotherapy treatment in stroke patients, with the main objective of determining their beneficial effects.

Read the detailed description

21 participants who will be divided by randomization between a control group and an experimental group. The results will be quantified with the following scales: Modified Asworth (spasticity). Daniels et al (muscle strength) Tinetti (balance and gait) Berg (balance) Joint range

02

Conditions studied

  • Stroke
  • Virtual Reality
  • Physical Therapy

Browse trials for

03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 21 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Universidad de Murcia is the lead sponsor of 77 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients receiving neurological physiotherapy treatment.
  • Patients who have suffered a stroke in the last two years.
  • Patients with an age range between 18 and 80 years old.
  • Patients with stroke with the ability to have minimal manual pressure with one limb.

Exclusion criteria

Exclusion Criteria:

  • Patients with stroke who also have degenerative diseases such as Alzheimer's or Parkinson's.
  • Stroke patients who do not understand the instructions.
  • Patients who have undergone surgery on the evaluated limbs.
  • Patients with scars that limit movement.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
21 participants (actual)

Study arms

  • Active comparator
    Control group

    Conventional neurological physiotherapy treatment.

    Other: Neurological physiotherapy

  • Experimental
    Experimental group

    Conventional neurological physiotherapy treatment with the use of virtual reality and video games.

    Other: Virtual reality and video games · Other: Neurological physiotherapy

Interventions

  • OtherVirtual reality and video games

    Use of a software in stroke patients' rehabilitation.

  • OtherNeurological physiotherapy

    Application of conventional physical therapy techniques.

06

What researchers measure

Primary outcomes

  1. Strength

    Strength measurement using the Daniels and Worthingham Scale. Minimum value = 0 , maximum value = 5. Higher scores mean a better outcome.

    Time frame: One month

  2. Spasticity

    Spasticity measurement using the Ashworth modified scale. Minimum value = 0, maximum value = 4. Higher scores mean a worse outcome.

    Time frame: One month

  3. Gait

    Gait measurement using the Tinetti scale. Minimum value = 0, maximum value = 28. Higher scores mean a better outcome.

    Time frame: One month

  4. Balance

    Balance using the Berg Balance Scale. Minimum value = 0, maximum value = 56. Higher scores mean a better outcome.

    Time frame: One month

  5. Joint range

    Joint range measure using goniometer

    Time frame: One month

07

Study locations

1 site
  • Universidad de Murcia
    Murcia, 300100, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05278403
Lead sponsor
Universidad de Murcia
Responsible party
Angel Martínez Carrasco (Professor Phd, Universidad de Murcia) — Principal investigator
First posted
Mar 14, 2022
Start date
May 6, 2022
Primary completion
May 20, 2022
Completion
Jun 13, 2022
Last update
Jun 22, 2022

Study contacts

Angel Martínez Carrasco, PhD
study director · Universidad de Murcia
Francisco Javier Peláez Vélez, Graduated
principal investigator · Universidad de Murcia

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion